Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Myopic degeneration, also called pathologic or degenerative myopia, is progressive damage to the back of the eye caused by elongation of a highly nearsighted eye. As the eyeball stretches, the retina, choroid, and supporting layers thin and can develop atrophy, cracks, a bulging area (staphyloma), and abnormal new blood vessels. These changes raise the risk of central vision loss, retinal detachment, and glaucoma.
read more about myopic degeneration ...Age-related macular degeneration is a disease of older adults driven by drusen and retinal pigment epithelium changes, with dry and wet forms. Myopic degeneration is driven by axial elongation of a nearsighted eye, which mechanically thins tissues and can trigger abnormal blood vessel growth. Both can affect the macula and blur central vision, but their causes, risk factors, and management differ.
In practice, imaging helps tell them apart. People with pathologic myopia show long eye length, posterior bulging, retinal cracks, patchy atrophy, and tilted optic discs, while age-related disease shows drusen and geographic atrophy. Treatment for active new blood vessels in either condition often uses anti-VEGF injections, adjusted to the specific diagnosis.
The root cause is progressive eye lengthening that stretches the back of the eye. Thinning of the supporting tissue reduces structural strength, leading to atrophic patches, cracks in the membrane beneath the retina, and a predisposition to abnormal blood vessel growth. Posterior bulging further distorts the macula and optic nerve.
Genetics and environment both contribute to high myopia. Family history, early myopia onset, intensive close work, and limited outdoor time are associated with higher risk for degenerative changes. Once eye length is significantly elongated, the eye is more prone to progressive tissue damage over time.
Many people notice gradual central blur, reduced contrast, and distortion when reading. A new gray spot, straight lines that look wavy, or a sudden drop in central vision can signal abnormal new blood vessel growth.
Flashes, a shower of floaters, or a curtain over vision may indicate a retinal tear or detachment. Some people develop peripheral vision changes or difficulty with night vision as atrophy expands. Any sudden change should be assessed promptly.
High myopia raises the risk of abnormal new blood vessels, macular atrophy, structural changes in the center of the retina, retinal holes, and retinal detachment. These complications can reduce reading vision and driving safety if missed. Yearly dilated exams, earlier visits for new distortion or floaters, and coordinated care with a retina specialist lower the chance of permanent loss.
The outlook improves when monitoring is consistent and treatment is prompt. Anti-VEGF therapy can restore or stabilize vision after abnormal blood vessel growth, while modern surgery addresses detachments and structural problems. Pairing medical care with practical tools like task lighting, magnification, and electronic contrast settings helps people stay independent while research into prevention and repair continues.
References
American Academy of Ophthalmology. Pathologic Myopia. https://eyewiki.org/Pathologic_Myopia
National Eye Institute. Myopia (Nearsightedness). https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/myopia
Mayo Clinic. Nearsightedness (myopia). https://www.mayoclinic.org/diseases-conditions/nearsightedness/symptoms-causes/syc-20375556
Cleveland Clinic. Degenerative Myopia. https://my.clevelandclinic.org/health/diseases/24843-degenerative-myopia
PubMed. Ohno-Matsui K. Pathologic myopia. https://pubmed.ncbi.nlm.nih.gov/25721970/
PubMed. Anti-VEGF for myopic choroidal neovascularization review. https://pubmed.ncbi.nlm.nih.gov/29324278/
AAO Preferred Practice. Retinal Detachment overview. https://www.aao.org/eye-health/diseases/retinal-detachment
Diagnosis relies on a dilated eye exam plus imaging. Optical coherence tomography shows thinning, fluid from abnormal vessels, or other structural changes. Advanced angiography helps confirm and map new blood vessels. Eye length, refraction, and widefield photography document progression and bulging.
Treatment targets complications. Anti-VEGF injections are first-line for abnormal new blood vessels and often require fewer injections than age-related disease. Selected cases benefit from photodynamic therapy with light-activated medication. Retinal tears or detachment need urgent repair. Low vision aids and updated glasses improve function. Myopia control strategies in children reduce future risk but do not reverse established degeneration in adults.
Refractive error can be corrected with glasses or contacts, but degenerative changes need medical or surgical care. Anti-VEGF treats abnormal blood vessel growth, while atrophy and bulging are monitored and supported with low vision tools.
Progression varies. Atrophy and bulging often enlarge slowly over years, while episodes of new blood vessel growth or retinal detachment can change vision over days to weeks. Regular imaging helps track pace.
It can threaten central vision through atrophy, scarring, or detachment. Timely diagnosis and treatment improve outcomes, and many people maintain useful sight with ongoing care.